| Ongoing (As of 31 Dec 2023) |
No.
|
Research Title |
Investigator
|
Status
|
| 1. |
DEDICATE REGISTRY (Abluminus Stent) – Drug Eluting Stent For Diabetic Patients In Coronary Artery Disease Treatment
Download |
Dato’ Sri Dr. Azhari Rosman |
Enrollment And Follow Up |
| 2. |
CTO Registry using the HYBRID CTO ALGORITHM at IJN. (Device : Crossboss & Stingray)
Download |
Datuk Dr Shaiful Azmi Yahaya |
Enrollment And Follow Up |
| 3. |
GSR DEFINE – Global SYMPLICITY Registry (GSR) Denervation Findings in Real World (DEFINE) is referred to as the GSR DEFINE study.
Download |
Dato’ Dr. Amin Ariff Nuruddin |
Enrollment And Follow Up |
| 4. |
SCORE REGISTRY(SCB Sequent Balloon) – Sequent® SCB ‘’All Comers’’ Post Market Clinical Follow up (PMCF)
Download |
Dato’ Dr. Amin Ariff Nuruddin |
Enrollment And Follow Up |
| 5. |
ZEUS – Effects of ziltivekimab versus placebo on cardiovascular outcomes in participants wiTh established atherosclerotic cardiovascular disease, chronic kidney disease and systemic inflammation
Download |
Dato’ Sri Dr Azhari Rosman |
Enrollment And Follow Up |
| 6. |
COMBINE-INTERVENE – COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events.
Download |
Dato’ Dr. Amin Ariff Nuruddin |
Enrollment And Follow Up |
| 7. |
UNISUS – A Phase 3, Prospective, Multicenter, Double-blind, Double-dummy, Randomized, Active-controlled, Parallel-group, Group-sequential, Adaptive, Event-driven Study to Compare Efficacy, Safety, and Tolerability of Macitentan 75mg Versus Macitentan 10mg in Patients with Pulmonary Arterial Hypertension, Followed by an Open-label Treatment Period with Macitentan 75mg
Download |
Dr Teoh Chee Kiang |
Enrollment And Follow Up |
| 8. |
OCEANIC – AF – Phase 3 study to investigate the efficacy and safety of the oral factor Xla(Fxla) inhibitor asundexian (BAY 2433334) compared with apixaban in participants with atrial fibrillation at risk for stroke
Download |
Dr Teoh Chee Kiang |
Enrollment And Follow Up |
| 9. |
PRIME-FFR – Prognostic impact of lesion-specific hemodynamic index and disease characteristics in patients with coronary artery disease assessed by fractional flow reserve
Download |
Dato’ Sri Dr. Azhari Rosman |
Enrollment And Follow Up |
| 10. |
GOAL-ASIA – Guideline Oriented Approach to Lipid Lowering In Asia-Pacific
Download |
Dr. Rafidah Abu Bakar |
Enrollment And Follow Up |
| 11. |
VICTORION REAL – An international prospective Real-world study to evaluate the Effectiveness and Adherence of incLisiran plus standard of care lipid-lowering therapy compared to standard of care therapy alone in patients with primary hypercholesterolemia or mixed dyslipidemia
Download |
Dato Sri Dr. Azhari Rosman |
Enrollment And Follow Up |
| 12. |
REVERSE TRIAL – Randomised Trial of Drug-Coated Balloon versus Drug-Eluting Stent for Clinical Outcomes in Patients with Large Coronary Artery Disease
Download |
Datuk Dr. Shaiful Azmi Yahaya |
Enrollment And Follow Up |
| 13. |
FARADISE – Real world Data collection in subjects treated with the FARAPULSEâ„¢ Pulsed Field Ablation system
Download |
Datuk Dr. Azlan Hussin |
Enrollment And Follow Up |
| 14. |
VICTORION-1 PREVENT –Â A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovascular events in high-risk primary prevention patients
Download |
Datuk Dr. Ahmad Khairuddin |
Enrollment And Follow Up |
| 15. |
Meres-1 Extend – A Prospective, Multinational, Multicenter, Single Arm, Open Label, Pilot Clinical Study Of Meres100 Sirolimus Eluting Bioresorbable Vascular Scaffold System In The Treatment Of De-Novo Native Coronary Artery Lesions
Download |
Dato’ Dr. Amin Ariff Nuruddin |
Follow Up |
| 16. |
ABSORBÂ BVS – Â Comparative Study In Real World Use Of The ABSORB Bioresorbable Vascular Scaffold In De Novo Coronary Artery Disease Among Diabetes And Non-Diabetes Patient In Institut Jantung Negara, Malaysia: A Prospective Post-Marketing Single-Center Registry
Download |
Datuk Dr Shaiful Azmi Yahaya |
Follow Up |
| 17. |
CONSEQUENT ALL COMERS – Clinical PMCF on Peripheral Arteries treated with SeQuent® Please OTW Paclitaxel Coated Balloon Catheter in an All Comer Patient Population
Download |
Datuk Dr Shaiful Azmi Yahaya |
Follow Up |
| 18. |
ISCHEMIA – International Study of Comparative Health Effectiveness With Medical and Invasive Approaches
Download |
Datuk Dr Ahmad Khairuddin |
Follow Up |
| 19. |
The EASTBOURNE Registry –Â The All-comers Sirolimus-coated balloon European registry.
Download |
Dato’ Dr. Amin Ariff Nuruddin |
Follow Up |
| 20. |
MYHF – Malaysian National Heart Failure Registry
Download |
Dato’ Dr. Azmee Bin Mohd Ghazi |
Follow Up |
| 21. |
SELECT STUDY – Semaglutide effects on cardiovascular outcomes in people with overweight or obesity
Download |
Dato’ Dr. Amin Ariff |
Follow Up |
| 22. |
CAAN – AF – Cardiac Resynchronization therapy (CRT) And AV Node ablation in Atrial Fibrillation
Download |
Dr. Shaiful Azmi Yahaya |
Follow Up |
| 23. |
PROTECT-ICD Trial –Â Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator (ICD) Implantation to Prevent Tachyarrhythmias Following Acute Myocardial Infarction
Download |
Dr. Surinder Kaur |
Follow Up |
| 24. |
CRYO AF GLOBAL REGISTRY
Download |
Dr. Surinder Kaur |
Follow Up |
| 25. |
A DUE – Prospective, multi-center, double-blind, randomized, active-controlled, triple-dummy, parallel-group, group-sequential, adaptive Phase 3 clinical study to compare the efficacy and safety of macitentan and tadalafil monotherapies with the corresponding fixed dose combination in subjects with pulmonary arterial hypertension (PAH), followed by an open-label treatment period with macitentan and tadalafil fixed dose combination therapy
Download |
Dr. Geetha Kandavello |
Follow Up |
| 26. |
MICRA AV
Download |
Datuk Dr. Azlan Hussin |
Follow Up |
| 27. |
BGSAMIRP – Blood-based Genomic Signatures in Acute Myocardial Infarction Risk Prediction
Download |
Dato’ Dr Amin Ariff Nuruddin |
Follow Up |
| 28. |
LEADR –Â Lead Evaluation for Defibrillation and Reliability
Download |
Dr. Surinder Kaur Khelae |
Follow Up |
| 29. |
ABILITY DIABETES –Â Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents versus Everolimus-Eluting Stents in Coronary Artery Disease Patients with Diebetes Mellitus Global.
Download |
Dato’ Dr. Amin Ariff Nuruddin |
Follow Up |
| 30. |
The AEGIS II Study –Â A Phase 3. Multicenter, Double- blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome.
Download |
Dato Sri Dr Azhari Rosman |
Follow Up |
| 31. |
FINEARTS – A multicentre, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure(NYHA II-IV) and EF ≥40%
Download |
Dr. Teoh Chee Kiang |
Follow Up |
| 32. |
STRIDE – Effects of semaglutide on functional capacity in patients with type 2 diabetes and peripheral arterial disease
Download |
Datuk Dr. Shaiful Azmi Yahaya |
Follow Up |
| 33. |
FIM-IBS – A Prospective, Non-randomized, Open-label, Non-comparative, First-in-Man Study to Evaluate the Feasibility and Safety of Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System
Download |
Datuk Dr Shaiful Azmi |
Follow Up |
| 34. |
RESTORE – A Prospective, Multicenter, Single-Arm, Open-Label, Phase 4 Study of the Effects of Selexipag on Right Ventricular Remodeling in Pulmonary Arterial Hypertension Assessed by Cardiac Magnetic Resonance Imaging
Download |
Dr Geetha Kandavello |
Follow Up |
| 35. |
NEOS-APAC STUDY – Asian Pacific post-market clinical follow-up study in patients with acute or chronic aortic dissection or aortic aneurysm treated with E-vita OPEN NEO.
Download |
Mr. Paneer Selvam |
Enrollment And Follow Up |
| 36. |
TOMORROW (paediatric use Of Macitentan To delay disease pRogRession on PAH Worldwide) – A multicentre, open-label, randomized, event-driven study to assess efficacy, safety and pharmacokinetics of macitentan versus standard of care in children with pulmonary arterial hypertension
Download |
Dr Geetha A/P Kandavello |
Enrollment And Follow Up |
| 37. |
VALOR – A Phase 2/3 Randomized, Placebo-Controlled, Double-blind, Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants with Heart Failure due to Systemic Left Ventricular Systolic Dysfunction
Download |
Dr. Marhisham Che Mood |
Enrollment And Follow Up |
| 38. |
SELEXIPAG – A Prospective, Multicentre, Open Label, Single Arm, Phase 2 Study to Investigate the Safety, Tolerability and Pharmacokinetics of Selexipag in Children with Pulmonary Arterial Hypertension
Download |
Dr. Geetha Kandavello |
Follow Up |
| 39. |
SALTO – A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group, Event-Driven, Group-Sequential Study with Open-Label Extension Period to Assess the Efficacy and Safety of Selexipag as Add-On Treatment to Standard of Care in Children Aged ≥2 to <18 years with Pulmonary Arterial Hypertension
Download |
Dr. Geetha Kandavello |
Follow Up |
| 40. |
RESTORE – A Prospective, Multicenter, Single-Arm, Open-Label, Phase 4 Study of the Effects of Selexipag on Right Ventricular Remodeling in Pulmonary Arterial Hypertension Assessed by Cardiac Magnetic Resonance Imaging (RESTORE)
Download |
Dr Geetha Kandavello |
Follow Up |
